Showing all 16 results
Acarbose Tablet
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets. The dosing is highly dependent on patient tolerance to GI side effects.
Active Ingredient Strength (Standard) Role Acarbose USP/BP 25 mg Initiation Dose (To minimize gas) Acarbose USP/BP 50 mg Standard Maintenance Dose Acarbose USP/BP 100 mg High Carbohydrate Load Dose Excipients Q.S. Microcrystalline Cellulose / Magnesium Stearate Glibenclamide & Metformin Hydrochloride Tablets
FreeProduct Composition & Standard Strengths
We supply this product in standardized Fixed-Dose Combinations (FDCs) designed for flexible clinical titration.
Active Ingredient Standard Strengths (per Tablet) Primary Clinical Function Metformin HCl 400 mg / 500 mg The Foundation: Reduces glucose production. Glibenclamide (Glyburide) 2.5 mg / 5 mg The Stimulator: Enhances insulin secretion. Excipients Pharma Grade The Matrix: Ensures stability of the FDC. Glibenclamide Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (Scored). The tablet is usually white or pink and scored to allow for precise dose titration.
Active Ingredient Strength (Standard) Role Glibenclamide USP/BP 1.25 mg Geriatric / Renal Impairment Glibenclamide USP/BP 2.5 mg Initial Dose / Mild Diabetes Glibenclamide USP/BP 5 mg Standard Therapeutic Dose Excipients Q.S. Lactose (Diluent) / Maize Starch Glipizide Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (Immediate Release) or Extended Release (XL/SR) Tablets using osmotic pump or matrix technology.
Active Ingredient Strength Formulation Role Glipizide USP/BP 5 mg Immediate Release Standard Initial Dose Glipizide USP/BP 10 mg Immediate Release High Potency Maintenance Glipizide USP/BP 5 mg / 10 mg Extended Release (XL) Once Daily (24hr Control) Excipients Q.S. Lactose / Stearic Acid Binder / Lubricant Linagliptin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Moisture-Shielded Film-Coated Tablet, packed exclusively in highly secure Alu-Alu blister strips to ensure the absolute chemical stability of the delicate API.
Active Ingredient Strength Primary Clinical Function Linagliptin USP/Ph.Eur. 5 mg The Universal Standard: A single, high-efficacy maintenance dose that applies to all adult patients, regardless of age, hepatic function, or severe renal impairment. Excipients Mannitol / Pregelatinized Starch / Copovidone / Magnesium Stearate / Premium Opadry Film Diluent / Disintegrant / Binder / Moisture-Barrier Coating (Engineered specifically without highly hygroscopic components to prevent moisture absorption, ensuring rapid disintegration and maximum bioavailability of the 5mg payload) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, massive-volume chronic diabetic dispensing regimens).
Metformin Hydrochloride & Glimepiride Tablets
FreeProduct Composition & Strength
We supply this product in Bilayer Tablets or Matrix Tablets packed in Alu-Alu or PVC/PVDC Blisters.
Product Strength Metformin HCl (SR) Glimepiride Common Name 500/1 mg 500 mg 1 mg G1 Tablet 500/2 mg 500 mg 2 mg G2 Tablet 1000/2 mg 1000 mg 2 mg Forte / DS Tablet 1000/4 mg 1000 mg 4 mg High Strength Metformin Hydrochloride & Pioglitazone Tablets
FreeProduct Composition & Strength
We supply this product as Sustained Release (SR) Matrix Tablets packed in Alu-Alu Blisters.
Product Strength Metformin HCl (SR) Pioglitazone Common Name 500/15 mg 500 mg 15 mg Pio-M 15 500/30 mg 500 mg 30 mg Pio-M 30 1000/15 mg 1000 mg 15 mg Pio-M Forte 1000/30 mg 1000 mg 30 mg Pio-M DS Pioglitazone Tablets
FreePioglitazone Tablets IP 15 mg
Each Uncoated tablet contains :
Pioglitazone Hydrochloride IP
Eq. To Pioglitazone 15 mgPioglitazone Tablets IP 30 mg
Each Uncoated tablet contains :
Pioglitazone Hydrochloride IP
Eq. To Pioglitazone 30 mgPioglitazone With Metformin Tablet
Each Film Coated Tablet contains :
Pioglitazone Hydrochloride IP
Eq. to Pioglitazone 15 mg
Metformin Hydrochloride IP 500 mgUsage: – Type 2 diabetes mellitus
Category: – Anti Diabetic drugs
Therapeutic category: – Anti Diabetic
Repaglinide & Metformin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or heavy-density PVC/PVDC blister strips to ensure the absolute chemical stability of the combined formulation.
Active Ingredient Strength Primary Clinical Function Repaglinide USP/Ph.Eur. 1 mg / 2 mg Short-acting meglitinide for rapid post-prandial (after-meal) insulin stimulation. Metformin Hydrochloride USP/Ph.Eur. 500 mg Global Clinical Standard: Biguanide for hepatic glucose suppression and insulin sensitization. Excipients Microcrystalline Cellulose / Povidone K30 / Croscarmellose Sodium / Poloxamer / Magnesium Stearate Diluent / Binder / Superdisintegrant / Surfactant (Engineered for immediate gastric dissolution and synchronized dual-absorption) *Pack Sizes: 10×10 or 3×10 Blisters (Optimized specifically for high-compliance 30-day chronic metabolic dispensing regimens tied directly to meal times).
Repaglinide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or heavy-density PVC/PVDC blister strips to ensure the absolute chemical stability of the highly sensitive meglitinide API.
Active Ingredient Strength Primary Clinical Function Repaglinide USP/Ph.Eur. 0.5 mg Base titration unit for treatment-naive patients or those with severe renal/hepatic impairment. Repaglinide USP/Ph.Eur. 1 mg / 2 mg Global Clinical Standard: Advanced maintenance doses for rapid post-prandial insulin stimulation. Excipients Microcrystalline Cellulose / Calcium Hydrogen Phosphate / Meglumine / Poloxamer / Magnesium Stearate Diluent / Stabilizer / Surfactant / Lubricant (Engineered for immediate gastric dissolution and ultra-fast systemic absorption) *Pack Sizes: 10×10 or 3×10 Blisters (Optimized specifically for high-compliance 30-day chronic metabolic dispensing regimens tied directly to meal times).
Saxagliptin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the sensitive active pharmaceutical ingredient.
Active Ingredient Strength Primary Clinical Function Saxagliptin (as Hydrochloride) INN/Ph.Eur. 2.5 mg Target dose for patients with moderate/severe renal impairment or those taking strong CYP3A4 inhibitors. Saxagliptin (as Hydrochloride) INN/Ph.Eur. 5 mg Global Clinical Standard: Maximum adult daily dose for the maintenance of Type 2 Diabetes. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate Diluent / Binder / Superdisintegrant (Engineered for immediate gastric dissolution and optimal bioavailability) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for high-compliance 30-day chronic metabolic dispensing regimens).
Sitagliptin Tablet
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets in Alu-Alu or PVC-PVDC blisters.
Active Ingredient Strength (Standard) Role Sitagliptin Phosphate IP/BP/USP 25 mg Renal Adjustment Dose Sitagliptin Phosphate IP/BP/USP 50 mg Intermediate Dose Sitagliptin Phosphate IP/BP/USP 100 mg Standard Adult Dose Excipients Q.S. Core & Coating Vildagliptin & Metformin Tablets
FreeProduct Composition & Strength
We supply this product as a highly advanced Film-Coated Tablet (Available in Immediate or Bilayer Sustained-Release formats), packed strictly in high-barrier Alu-Alu blister strips. Alu-Alu packaging is completely non-negotiable, as Vildagliptin is intensely sensitive to moisture degradation.
Active Ingredient Strength & Format Primary Clinical Use Vildagliptin INN/Ph.Eur. 50 mg (Immediate Release Layer) Rapid dissolution to block DPP-4 and manage post-prandial incretin levels. Metformin Hydrochloride USP/BP 500 mg / 850 mg / 1000 mg (IR or SR) Provides continuous baseline hepatic glucose suppression and peripheral sensitization. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Titanium Dioxide SR Polymer Matrix / Diluent / Film-Coating (Engineered for precise kinetic release) Vildagliptin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated or Film-Coated Tablet, packed strictly in high-barrier Alu-Alu blister strips to guarantee absolute protection from moisture and environmental degradation.
Active Ingredient Strength Primary Clinical Use Vildagliptin INN/Ph.Eur. 50 mg Standard Adult Dose for monotherapy or adjunctive combination therapy. Excipients Microcrystalline Cellulose / Anhydrous Lactose / Magnesium Stearate Diluent / Lubricant (Engineered for optimal compressibility and rapid gastric dispersion) Voglibose & Metformin Tablets
FreeProduct Composition & Strength
We supply this product as a highly advanced Bilayer Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips. Alu-Alu packaging is completely non-negotiable, as Voglibose is highly sensitive to moisture degradation.
Active Ingredient Strength & Format Release Profile Function Voglibose USP/BP/JP 0.2 mg / 0.3 mg (Immediate Release Layer) Instantly dissolves in the gut to block carbohydrate absorption during the meal. Metformin Hydrochloride USP/BP 500 mg (Sustained Release Matrix) Slow-release polymer matrix providing continuous 24-hour hepatic suppression. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose SR Polymer Matrix / Diluent (Engineered to control precise dissolution rates) Voglibose Tablet
FreeVoglibose tablets are oral anti-diabetic medications primarily composed of the active ingredient Voglibose, a synthetic alpha-glucosidase inhibitor. They are typically available in strengths of 0.2 mg or 0.3 mg.
